News
30 June 2017

Cancer Research UK reopens its £20 million Grand Challenge for application

Following the investment of over £70 million in four global teams in 2016, Cancer Research UK (CRUK) is now accepting applications through Oct. 12. for multidisciplinary teams willing to take on eight challenges identified as toughest in the cancer fight.

CRUK’s Grand Challenge is an ambitious worldwide research grant, offering a series of £20 million awards over the span of five years to teams who dare to try novel approaches at scale in the pursuit of discovery. In the first round, four teams were funded from 56 entries with the aims of identifying preventable causes of cancer, creating virtual maps of tumours, preventing unnecessary breast cancer treatment and studying tumour metabolism from every angle. Once more, CRUK is seeking experts from any country working to tackle some of the biggest barriers to progress: Tissue specificity, tumour vaccinology, treatment regimens, dormancy, lethal vs. non-lethal cancers, artificial intelligence, microbiota and cancer causes.

“By bringing together some of the world’s leaders in cancer research we’ve come up with eight key challenges that, if answered, could see research leap ahead at new speeds," said Sir Harpal Kumar, Cancer Research UK.

Applications will be accepted through Oct. 12 and awards will be announced in autumn 2018.

Last update

Friday 07 June 2019

Share this page

Related content

Branded poster for the 60th anniversary of the International Agency for Research on Cancer

The International Agency for Research on Cancer will hold its 60th Anniversary Scientific Conference in Lyon from 19–21 May 2026, with UICC as a partner. Register here to be part of this unique event.

Several roundtables with diverse participants (women) at a workshop

UICC member organisations in 10 countries significantly increased HPV awareness and uptake of vaccination through community-driven strategies, with support from UICC grants, demonstrating the crucial role of civil society in advancing global cervical cancer elimination goals.